RANDOMIZED, DOUBLE-BLIND PHASE 2 STUDY OF AXITINIB (AG-013736) WITH OR WITHOUT DOSE TITRATION IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA

Update Il y a 4 ans
Reference: EUCTR2008-007786-23

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To compare the objective response rate (ORR) in patients receiving axitinib with or without dose titration (Arms A and B)


Inclusion criteria

  • Metastatic RCC